Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohns Disease and Intestinal TuberculosisReportar como inadecuado




Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohns Disease and Intestinal Tuberculosis - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Aim

To explore the diagnostic models of Crohn’s disease CD, Intestinal tuberculosis ITB and the differential diagnostic model between CD and ITB by analyzing serum proteome profiles.

Methods

Serum proteome profiles from 30 CD patients, 21 ITB patients and 30 healthy controls HCs were analyzed by using weak cationic magnetic beads combined with MALDI-TOF-MS technique to detect the differentially expressed proteins of serum samples. Three groups were made and compared accordingly: group of CD patients and HCs, group of ITB patients and HCs, group of CD patients and ITB patients. Wilcoxon rank sum test was used to screen the ten most differentiated protein peaks P < 0.05. Genetic algorithm combining with support vector machine SVM was utilized to establish the optimal diagnostic models for CD, ITB and the optimal differential diagnostic model between CD and ITB. The predictive effects of these models were evaluated by Leave one out LOO cross validation method.

Results

There were 236 protein peaks differently expressed between group of CD patients and HCs, 305 protein peaks differently expressed between group of ITB patients and HCs, 332 protein peaks differently expressed between group of CD patients and ITB patients. Ten most differentially expressed peaks were screened out between three groups respectively P < 0.05 to establish diagnostic models and differential diagnostic model. A diagnostic model comprising of four protein peaks M-Z 4964, 3029, 2833, 2900 can well distinguish CD patients and HCs, with a specificity and sensitivity of 96.7% and 96.7% respectively. A diagnostic model comprising four protein peaks M-Z 3030, 2105, 2545, 4210 can well distinguish ITB patients and HCs, with a specificity and sensitivity of 93.3% and 95.2% respectively. A differential diagnostic model comprising three potential biomarkers protein peaks M-Z 4267, 4223, 1541 can well distinguish CD patients and ITB patients, with a specificity and sensitivity of 76.2% and 80.0% respectively. Among the eleven protein peaks from the diagnostic models and differential diagnostic model, two have been successfully purified and identified, Those two peaks were M-Z 2900 from the diagnostic model between CD and HCs and M-Z 1541 from the differential diagnostic model between CD and ITB. M-Z 2900 was identified as appetite peptide, M-Z 1541 was identified as Lysyl oxidase-like 2 LOXL-2.

Conclusion

The differently expressed protein peaks analyzed by serum proteome with weak cationic magnetic beads combined MALDI-TOF-MS technique can effectively distinguish CD patients and HCs, ITB patients and HCs, CD patients and ITB patients. The diagnostic model between CD patients and HCs consisting of four protein peaks M-Z 4964, 3029, 2833, 2900, the diagnostic model between ITB patients and HCs comprising four protein peaks M-Z 3030, 2105, 2545, 4210 and the differential diagnostic model between CD patients and ITB patients comprising three protein peaks M-Z 4267, 4223, 1541 had high specificity and sensitivity and can contribute to diagnoses of CD, ITB and the differential diagnosis between CD and ITB. Two proteins from the diagnostic model of CD and the differential diagnostic model between CD and ITB were identified. Further experiments are required using a larger cohort of samples.



Autor: Fenming Zhang, Chengfu Xu, Longgui Ning, Fengling Hu, Guodong Shan, Hongtan Chen, Ming Yang, Wenguo Chen, Jiekai Yu, Guoqiang Xu

Fuente: http://plos.srce.hr/



DESCARGAR PDF




Documentos relacionados